Week In Review: CStone Pharma To Develop Novel Drugs For China With $150 Million In Startup Capital By: TalkMarkets July 09, 2016 at 14:28 PM EDT CStone Pharma, a Shanghai-Suzhou startup, closed a $150 million Series A round to license novel drugs. Read More >> Related Stocks: Beigene Ltd ADR